Erbe Elektromedizin GmbH has introduced the FiAPC® plus probes, a significant innovation in the field of electrosurgery aimed at advancing the precision and control of argon plasma coagulation (APC) procedures. Specifically designed for gastrointestinal and pulmonary endoscopy, the FiAPC® plus probes are equipped with features that optimize energy delivery and plasma beam formation while enhancing tip control and procedural safety. The integration of a thermally insulated tip helps minimize heat buildup, reducing tissue sticking and ensuring consistent plasma output even in anatomically complex areas. This evolution reflects Erbe’s long-standing commitment to refining APC technology for higher performance and clinical effectiveness.

The FiAPC® plus probes offer physicians flexibility with a range of configurations—axial, lateral, and circumferential—tailored to meet diverse clinical demands. Their compatibility with Erbe’s advanced APC modes (preciseAPC®, pulsedAPC®, and forcedAPC®) and seamless integration with the APC 3 and VIO® 3n Fire generator systems allow clinicians to fine-tune tissue effects according to specific procedural goals. This level of control is especially critical when operating in thermosensitive areas like the cecum or bronchial pathways, where reduced thermal spread and consistent coagulation are essential. These probes not only improve safety and efficacy but also streamline workflows through intelligent system recognition and pre-configured settings.

With CE mark availability and a growing global rollout, FiAPC® plus represents Erbe’s ongoing pursuit of clinical partnership and innovation. In addition to the new technology, the company is investing in comprehensive education and support, equipping GI endoscopists and pulmonologists with training modules, hands-on courses, and expert guidance. By aligning cutting-edge engineering with physician-centered design and robust clinical support, Erbe continues to push the boundaries of APC technology—reaffirming its leadership in minimally invasive therapeutic solutions and advancing patient outcomes across key specialties.